Frontiers in Microbiology (Dec 2020)
Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients
- Chong Wang,
- Chong Wang,
- Jiqian Xu,
- Shaoyuan Wang,
- Shangwen Pan,
- Jiancheng Zhang,
- Yang Han,
- Yang Han,
- Yang Han,
- Muhan Huang,
- Muhan Huang,
- Di Wu,
- Di Wu,
- Qingyu Yang,
- Xiaobo Yang,
- Yang Yang,
- Ting Shu,
- Ting Shu,
- Xiaojing Zou,
- Ruiting Li,
- Yufeng Luo,
- Runqing Yao,
- Yaxin Wang,
- Yang Qiu,
- Yang Qiu,
- Yu Wang,
- Ding-Yu Zhang,
- Qun Yao,
- Yongpan Yan,
- Xi Zhou,
- Xi Zhou,
- Xi Zhou,
- You Shang,
- You Shang,
- You Shang
Affiliations
- Chong Wang
- Center for Precision Translational Medicine of Wuhan Institute of Virology & Guangzhou Women and Children's Medical Center, Guangzhou Women and Children's Medical Center, Guangzhou, China
- Chong Wang
- Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology & Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, China
- Jiqian Xu
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Shaoyuan Wang
- Gencode Diagnostics Inc., Beijing, China
- Shangwen Pan
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Jiancheng Zhang
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Yang Han
- Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology & Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, China
- Yang Han
- State Key Laboratory of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, China
- Yang Han
- Center for Translational Medicine, Wuhan Jinyintan Hospital, Wuhan, China
- Muhan Huang
- Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology & Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, China
- Muhan Huang
- State Key Laboratory of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, China
- Di Wu
- Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology & Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, China
- Di Wu
- State Key Laboratory of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, China
- Qingyu Yang
- Center for Translational Medicine, Wuhan Jinyintan Hospital, Wuhan, China
- Xiaobo Yang
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Yang Yang
- Gencode Diagnostics Inc., Beijing, China
- Ting Shu
- State Key Laboratory of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, China
- Ting Shu
- Center for Translational Medicine, Wuhan Jinyintan Hospital, Wuhan, China
- Xiaojing Zou
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Ruiting Li
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Yufeng Luo
- Gencode Diagnostics Inc., Beijing, China
- Runqing Yao
- Gencode Diagnostics Inc., Beijing, China
- Yaxin Wang
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Yang Qiu
- Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology & Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, China
- Yang Qiu
- State Key Laboratory of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, China
- Yu Wang
- Life Science Institute, Jinzhou Medical University, Jinzhou, China
- Ding-Yu Zhang
- Center for Translational Medicine, Wuhan Jinyintan Hospital, Wuhan, China
- Qun Yao
- Center for Translational Medicine, Wuhan Jinyintan Hospital, Wuhan, China
- Yongpan Yan
- Gencode Diagnostics Inc., Beijing, China
- Xi Zhou
- Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology & Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, China
- Xi Zhou
- State Key Laboratory of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, China
- Xi Zhou
- Center for Translational Medicine, Wuhan Jinyintan Hospital, Wuhan, China
- You Shang
- Department of Critical Care Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- You Shang
- Center for Translational Medicine, Wuhan Jinyintan Hospital, Wuhan, China
- You Shang
- Tongji Medical College, Institute of Anesthesiology and Critical Care Medicine, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- DOI
- https://doi.org/10.3389/fmicb.2020.600989
- Journal volume & issue
-
Vol. 11
Abstract
SARS-coronavirus-2–induced immune dysregulation and inflammatory responses are involved in the pathogenesis of coronavirus disease-2019 (COVID-19). However, very little is known about immune cell and cytokine alterations in specific organs of COVID-19 patients. Here, we evaluated immune cells and cytokines in postmortem tissues, i.e., lungs, intestine, liver, kidneys, and spleen of three patients with COVID-19. Imaging mass cytometry revealed monocyte, macrophage, and dendritic cell (DC) infiltration in the lung, intestine, kidney, and liver tissues. Moreover, in patients with COVID-19, natural killer T cells infiltrated the liver, lungs, and intestine, whereas B cells infiltrated the kidneys, lungs, and intestine. CD11b+ macrophages and CD11c+ DCs also infiltrated the lungs and intestine, a phenomenon that was accompanied by overproduction of the immunosuppressive cytokine interleukin (IL)-10. However, CD11b+ macrophages and CD11c+ DCs in the lungs or intestine of COVID-19 patients did not express human leukocyte antigen DR isotype. In contrast, tumor necrosis factor (TNF)-α expression was higher in the lungs, intestine, liver, and kidneys, but not in the spleen, of all COVID-19 patients (compared to levels in controls). Collectively, these findings suggested that IL-10 and TNF-α as immunosuppressive and pro-inflammatory agents, respectively,—might be prognostic and could serve as therapeutic targets for COVID-19.
Keywords
- imaging mass cytometry (IMC)
- COVID-19
- organ specific response
- immune dysregulation
- inflammatory response